Agalsidase-Beta Therapy for Advanced Fabry Disease
Maryam Banikazemi(University of Alabama at Birmingham), Robert J. Desnick(Icahn School of Medicine at Mount Sinai), Jan Bultas(Charles University), David G. Warnock(University of Alabama at Birmingham), Daniel G. Bichet(Hôpital du Sacré-Cœur de Montréal), Richard S. Finkel(St. Jude Children's Research Hospital), Stephen Waldek, William R. Wilcox(Emory University), Chester B. Whitley(University of Minnesota), Seymour Packman(University of California, San Francisco)
Cited by 565
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase
|Nature Genetics|1993|1.4k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823